Evidence map›Paper›PMID 21632558›Full record

ArticleThe Journal of general virology2011

Mutations in the G-H loop region of ephrin-B2 can enhance Nipah virus binding and infection.

Junfa Yuan, Glenn Marsh, Dimple Khetawat, Christopher C Broder, Lin-Fa Wang, Zhengli Shi

Open access · greenAbstract read
In one paragraph

Article in The Journal of general virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Pseudotyped Virus for Henipavirus.Advances in experimental medicine and biology · 2023
    Review
  10. Pseudotyped Viruses.Advances in experimental medicine and biology · 2023
    Article
  11. Article
  12. Article
  13. Review
  14. Henipavirus receptor usage and tropism.Current topics in microbiology and immunology · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Junfa YuanState Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, PR China.
Glenn MarshAustralian Animal Health Laboratory, Commonwealth Scientific and Industrial Research Organization Livestock Industries, Geelong, Victoria, Australia.
Dimple KhetawatDepartment of Microbiology, Uniformed Services University, Bethesda, MD 20814, USA.
Christopher C BroderDepartment of Microbiology, Uniformed Services University, Bethesda, MD 20814, USA.
Lin-Fa WangAustralian Animal Health Laboratory, Commonwealth Scientific and Industrial Research Organization Livestock Industries, Geelong, Victoria, Australia.
Zhengli ShiState Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, PR China.
Australian Centre for Disease Preparedness · AUUniformed Services University of the Health Sciences · USChinese Academy of Sciences · CNWuhan Institute of Virology · CN

Funding

Vaccines and Therapeutics for Nipah and Hendra virusU01AI077995 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI BRODER, CHRISTOPHER C · 2008 to 2012
$5.5M
NIAID NIH HHS U01 AI077995
6 · The paper itself

Abstract

Nipah virus (NiV) and Hendra virus (HeV) are zoonotic paramyxoviruses classified in the genus Henipavirus of the family Paramyxoviridae. The entry of henipaviruses occurs through a pH-independent membrane-fusion mechanism mediated by the cooperation of the viral attachment (G) and fusion (F) envelope glycoproteins following virion binding to susceptible host cells. Virus attachment is mediated by the interaction of the G glycoprotein with ephrin-B2 or ephrin-B3, which were identified as the functional receptors of henipavirus. Several residues of the G glycoprotein that are important for receptor binding have been determined through mutagenesis and structural analyses; however, similar approaches have not been carried out for the viral receptor ephrin-B2. Here, an alanine-scanning mutagenesis analysis was performed to identify residues of ephrin-B2 which are critical for NiV binding and entry by using an NiV-F- and -G-glycoprotein pseudotyped lentivirus assay. Results indicated that the G-H loop of ephrin-B2 was indeed critical for the interaction between ephrin-B2 and NiV-G. Unexpectedly, however, some alanine-substitution mutants located in the G-H loop enhanced the infectivity of the NiV pseudotypes, in particular an L124A mutation enhanced entry >30-fold. Further analysis of the L124A ephrin-B2 mutant demonstrated that an increased binding affinity of the mutant receptor with NiV-G was responsible for the enhanced infectivity of both pseudovirus and infectious virus. In addition, cell lines that were stably expressing the L124A mutant receptor were able to support NiV infection more efficiently than the wild-type molecule, potentially providing a new target-cell platform for viral isolation or virus-entry inhibitor screening and discovery.

Indexed as

Virus InternalizationAmino Acid SubstitutionAnimalsCell LineEphrin-B2HumansMutagenesis, Site-DirectedMutant ProteinsNipah VirusProtein BindingReceptors, VirusSpodopteraViral Structural ProteinsEphrin-B2Mutant ProteinsReceptors, VirusViral Structural Proteins

Identifiers

PMID21632558
PMCPMC7879936
OpenAlexW2112972263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.